Formulation

When looking to do good, many companies choose to focus on children’s health, particularly in developing countries.

The potential of inhaled drug delivery goes beyond traditional respiratory medicine.

With approximately 80 percent of new drugs suffering from poor solubility and bioavailability, understanding solid form is more important than ever.

High-throughput excipient discovery looks set to boost oral bioavailability.

Pfizer researchers share the story behind the first JAK inhibitor for rheumatoid arthritis

What are biosynthetic cannabinoids? And what do they mean for pharma?

How unravelling the complex chemistry of the cannabis plant can lead to new medicines

What's causing pharma's fascination with cannabinoids and cannabis?

How easy will it be to bring a new solid oral dosage form to market?

How controlled release can lead to better compliance.